STAT3 and ovarian carcinoma: Of interest, NANOG expression correlated positively with levels of total and phosphorylated STAT3, suggesting a role for NANOG-mediated EMT and drug-resistance through the activation of the STAT3 pathway in epithelial ovarian cancer [41].